All articles — 4345 total
Global Business Travel Group arrived at today's Q1 earnings report carrying something heavier than a quarterly print: a $6.3 billion all-cash acquisition agreement with Long Lake Management at $9.50 per share. The…
SoundHound AI arrives at its May 7 earnings print carrying one of the most extreme short-side setups in the market — 38% of the free float sold short, a borrow market that has effectively run dry, and a cost to borrow…
BRC Inc. heads into its Q1 2026 earnings report with short sellers pulling back — yet the broader positioning picture remains charged. The clearest signal is in the short interest trend itself. Bearish positioning has…
TPG Inc. heads into its May 7 earnings report with the Street growing more constructive — even as short sellers quietly build positions and options traders ease off their defensiveness. The clearest signal into the…
Akanda Corp. heads into its May 7 earnings print as one of the most compressed and turbulent small-cap set-ups on Nasdaq — a stock up more than 1,200% in a month, now absorbing a short-seller attack, with the borrow…
Quoin Pharmaceuticals heads into its May 7 earnings event with the lending market completely dried up — a structural tension that sits at the heart of the current setup. Every share available to borrow has been lent…
Arhaus heads into its May 7 Q1 results with a deteriorating analyst consensus and short sellers quietly rebuilding positions, as the stock hovers near multi-year lows. The analyst picture is uniformly cautious. Every…
YMAT enters tomorrow's earnings print with its borrow cost far above what a stock of its size would normally attract — a signal that the lending market has been unusually active around this micro-cap leisure products…
Crescent Energy heads into its Q1 2026 earnings report with options traders unusually bullish — a sharp contrast to short sellers who have been quietly covering for weeks. The options signal is the standout. The…
RDW's earnings tomorrow are almost incidental to the bigger story: its founding private equity sponsor has been aggressively exiting. AE Industrial Partners LP dumped more than 28 million shares over a ten-day stretch…
GXO Logistics walks into today's first-quarter earnings report nursing a 18% one-day loss and a 19% slide on the week — a brutal reset that now frames the entire print as a credibility test. The price action overwhelms…
CVRX reports Q1 2026 results on May 6 carrying fresh short-side momentum, a recent earnings track record of sharp declines, and a stock already down 13% over the past month. Short sellers have been adding positions…
AGL enters its Q1 2026 earnings release tomorrow with the sharpest analyst signal of the pre-print period arriving just hours ago: JP Morgan's Lisa Gill downgraded the stock to Underweight with a $21 target — a direct…
Design Therapeutics arrives at its May 8 Q2 earnings call on a genuine high. The stock jumped 23% on April 28 after Q1 EPS of -$0.29 beat estimates by $0.05 and the company narrowed its net loss. It has since pulled…
Coinbase Global reports Q1 2026 results on May 7 with short sellers firmly entrenched and options traders adding hedges into a stock that has already reclaimed a fifth of its value in a month. Short interest is the…
Valaris heads into its May 6 earnings release with a notable divergence between options traders turning more defensive and short sellers quietly reducing exposure. The clearest pre-earnings signal is in options. The…
AppLovin heads into its May 6 Q1 print with options sentiment at its most cautious in twelve months — a sharp contrast to a stock that has rallied hard. The options signal is the clearest tell in the setup. The…
Nuvation Bio heads into its May 8 earnings report with short sellers making a clear statement — and options traders ignoring them entirely. Short interest has become the dominant feature of the positioning picture. At…
CLNN heads into its May 8 earnings call riding an FDA-driven momentum spike — the most significant catalyst update in the company's recent history. The FDA news is the story. On May 4, Clene announced the agency…
Damora Therapeutics walks into its May 7 earnings report carrying two distinctly uncomfortable facts: a CFO who just stepped down and a short interest that has tripled in six weeks. The headline from Monday — CFO Lori…
